186692-46-6

URI: https://gptkb.org/entity/186692-46-6

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:chemical_compound
gptkbp:approvalYear	2015
gptkbp:approvedBy	gptkb:FDA
gptkbp:ATCCode	L01EB37
gptkbp:CASNumber	gptkb:186692-46-6
gptkbp:developedBy	gptkb:AstraZeneca
gptkbp:hasMolecularFormula	C28H33N7O2
gptkbp:hasUNII	7A5I1C1W3F
gptkbp:indication	gptkb:non-small_cell_lung_cancer
gptkbp:isApprovedDrug	true
gptkbp:IUPACName	gptkb:N-(2-{2-Dimethylamino)ethyl}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
gptkbp:marketedAs	gptkb:Tagrisso
gptkbp:mechanismOfAction	gptkb:EGFR_tyrosine_kinase_inhibitor
gptkbp:molecularWeight	499.6 g/mol
gptkbp:PubChem_CID	gptkb:DB09330 CHEMBL3185146 71496458
gptkbp:routeOfAdministration	oral
gptkbp:synonym	gptkb:AZD9291 gptkb:Osimertinib
gptkbp:bfsParent	gptkb:roscovitine
gptkbp:bfsLayer	8
https://www.w3.org/2000/01/rdf-schema#label	186692-46-6